Evolent Health (NYSE:EVH) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.05) by 60 percent. This is a 133.33 percent decrease over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $496.246 million which missed the analyst consensus estimate of $534.669 million by 7.19 percent. This is a 2.60 percent increase over sales of $483.649 million the same period last year.